- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02667366
Effectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary Care
Improving Access to Evidence-based Treatment for Depression: Effectiveness and Cost-effectiveness of Telephone-delivered Cognitive Behavioral Therapy (CBT) in Primary Care
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The overall purpose of the study is to examine the effectiveness of telephone psychotherapy (Tel-PT) for the treatment of mild to moderate depression on different outcome-levels and under clinically representative conditions in Swiss primary health care. The randomized-controlled trial (RCT) will evaluate the primary hypothesis that Tel-PT is more effective than routine primary care (i.e. treatment as usual, TAU), more specifically, that it leads to significant higher reduction in depression severity than TAU at follow-up.
The intervention group (IG) receives a manualized short-term cognitive behavioral treatment, which is the adapted German version of the program "Creating a balance" developed in the USA. The therapy consists of one face-to-face and 8-12 telephone contacts and is carried out by a licensed psychotherapist.
More concrete, recruitment and inclusion of the patients will be carried out by the participating general practitioners (GPs). GPs will be instructed to screen patients at risk for depression, especially those revealing diffuse somatic symptoms and suffering from chronic diseases. If positively screened, patient's depressive symptoms are assessed with Patient Health Questionnaire (PHQ-9) and diagnosed according to ICD-10.
All GPs will receive an initial training prior to their participation, providing them with study information and procedures as well as training in screening procedure, psychodiagnostics and study enrolment.
Eligible patients are provided with detailed study information and asked to participate. Subsequently, patients will give informed consent. Patients will then be included into the study and fill out the baseline questionnaires (t0). After that, randomization will be carried out at the University of Zurich, based on an appropriately created computer algorithm. Both GPs and patients are informed about the results by the study team within two days. Subsequently, patients in control group (CG) will receive regular text messages and patients in the intervention group (IG) will be called by the study therapist to schedule an initial appointment.
In case of positive results, the overarching objective is the optimization of mental health services for depressed patients by implementing an evidence-based, accessible and cost-effective treatment option into primary care.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Zurich, Suíça, 8050
- University of Zurich
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- PHQ-9 score of > 5 and ≤15.
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- Minimum age of 18 years
- Diagnosis of mild to moderate depression according to ICD-10 (F32.0, F32.1, F33.0, F33.1)
Exclusion Criteria:
- Patients currently being in psychotherapeutic treatment or treatment in past three months
- Suicidal tendencies or suicidality
- Insufficient knowledge of German language
- Health condition that does not allow questionnaire completion
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Tel-PT
Tel-PT receives a manualized short-term CBT.
Treatment consists of one initial face-to-face appointment and 8-12 subsequent telephone sessions between patient and licensed therapist.
Each telephone contact lasts between 20 and 30 minutes and take place on a weekly and later biweekly basis.
|
|
|
Comparador Ativo: TAU and text messages
Control Group receives treatment as usual and additionally weekly text messages containing general information about depression.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in depressive symptoms
Prazo: t0 (baseline) and t2 (12 months after baseline)
|
The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
|
t0 (baseline) and t2 (12 months after baseline)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in depressive symptoms
Prazo: t0 (baseline) and t1 (four months after baseline)
|
The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
|
t0 (baseline) and t1 (four months after baseline)
|
|
Response
Prazo: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Response defined as 50% reduction in the PHQ-9.
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
|
Change in health-related quality of life
Prazo: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Change in health-related quality of life is measured with the 12-Item Short Form Health Survey (SF-12; Bullinger & Kirchberger, 1998).
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
|
Self-efficacy for management and relapse prevention in depression
Prazo: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Depression self-efficacy scale for management and relapse prevention (Bush et al., 2001).
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
|
Cost-effectiveness
Prazo: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Health care utilization and productivity loss will be measured with an adapted version of the Client Sociodemographic and Service Receipt Inventory (CSSRI; Chisholm et al., 2000).
For Switzerland, country-specific unit costs will be employed to calculate direct and indirect costs.
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
|
Cost-effectiveness
Prazo: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Health-related quality of life for the economic analyses will be measured using the EQ-5D-5L (The EuroQuol Group, 1990), Quality-adjusted life years (QALYs) based on the EQ-5D index will be determined and the incremental cost-effectiveness ratio (ICER) will be computed.
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Acceptance and satisfaction with the intervention
Prazo: t1 (four months after baseline)
|
Patients' and therapists' acceptance and satisfaction with the intervention will be assessed by a self-constructed questionnaire.
|
t1 (four months after baseline)
|
|
Process and structural variable
Prazo: t1 (four months after baseline), t2 (12 months after baseline)
|
Mean duration of telephone contacts
|
t1 (four months after baseline), t2 (12 months after baseline)
|
|
Process and structural variable
Prazo: t1 (four months after baseline), t2 (12 months after baseline)
|
Mean number of telephone contacts.
|
t1 (four months after baseline), t2 (12 months after baseline)
|
|
Process and structural variable
Prazo: t1 (four months after baseline), t2 (12 months after baseline)
|
Dropout rate
|
t1 (four months after baseline), t2 (12 months after baseline)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Birgit Watzke, Prof, University of Zurich, Department of Clinical Psychology and Psychotherapy Research
Publicações e links úteis
Publicações Gerais
- Simon GE, Ludman EJ, Tutty S, Operskalski B, Von Korff M. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA. 2004 Aug 25;292(8):935-42. doi: 10.1001/jama.292.8.935.
- Löwe, B, Spitzer, RL, Zipfel, S, & Herzog, W. Gesundheitsfragebogen für Patienten (PHQ-D): Manual und Testunterlagen. Pfizer. Karlsruhe: 2002.
- Watzke B, Heddaeus D, Steinmann M, Konig HH, Wegscheider K, Schulz H, Harter M. Effectiveness and cost-effectiveness of a guideline-based stepped care model for patients with depression: study protocol of a cluster-randomized controlled trial in routine care. BMC Psychiatry. 2014 Aug 20;14:230. doi: 10.1186/s12888-014-0230-y.
- Bush, T, Russo, J, Ludman, E, Lin, E, Von Korff, M, Simon, G, Walker, E. Perceived self-efficacy for depression self-management. A reliable and valid self-report measure with predictive validity: Poster presentation at the American Psychological Society Meeting, June 2001. Toronto, Canada.
- Bullinger, M, & Kirchberger, I. Fragebogen zum Gesundheitszustand. Hogrefe. Göttingen: 1998.
- Haller E, Besson N, Watzke B. "Unrigging the support wheels" - A qualitative study on patients' experiences with and perspectives on low-intensity CBT. BMC Health Serv Res. 2019 Oct 9;19(1):686. doi: 10.1186/s12913-019-4495-1.
- Watzke B, Haller E, Steinmann M, Heddaeus D, Harter M, Konig HH, Wegscheider K, Rosemann T. Effectiveness and cost-effectiveness of telephone-based cognitive-behavioural therapy in primary care: study protocol of TIDe - telephone intervention for depression. BMC Psychiatry. 2017 Jul 19;17(1):263. doi: 10.1186/s12888-017-1429-5.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- BW-0417
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Tel-PT
-
Universitätsklinikum Hamburg-EppendorfConcluído
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)ConcluídoHIV | Adesão à MedicaçãoÍndia
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Concluído
-
Rigshospitalet, DenmarkLundbeck FoundationConcluído
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanConcluído
-
Vanderbilt University Medical CenterUnited States Department of DefenseRecrutamentoDegeneração da Coluna Cervical | Cirurgia ACDFEstados Unidos
-
Promontory Therapeutics Inc.Ativo, não recrutandoNeoplasias urogenitais | Neoplasias por local | Neoplasias Genitais Masculinas | Neoplasias prostáticas | Tumores Sólidos Avançados | mCRPC | Câncer de Próstata Metastático Resistente à Castração | CRPC | PT-112Estados Unidos, França
-
Alabama Physical Therapy & AcupunctureUniversidad Rey Juan CarlosConcluídoFascite PlantarEstados Unidos
-
Alabama Physical Therapy & AcupunctureUniversidad Rey Juan CarlosConcluídoOsteoartrite do joelhoEstados Unidos
-
NYU Langone HealthConcluídoArtroplastia Total da ArticulaçãoEstados Unidos